NDC11 64764017502
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 64764-0175-02 | 64764-0175 |
| 64764-0175-2 | 64764-0175 |
| 64764-175-02 | 64764-175 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexilant | DEXLANSOPRAZOLE | Takeda Pharmaceuticals America, Inc. | 9819f033-3bbe-442e-8e92-45fec77b237d | 2025-02-17 | Warnings, Adverse reactions | 64764-175-02 64764-175 64764017502 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.